Importance of UDP-glucuronosyltransferase 1A1*6 for irinotecan toxicities in Japanese cancer patients

被引：40
|
作者：
Sai, Kimie [1 ]
Saito, Yoshiro [2 ]
Sakamoto, Hiromi [3 ]
Shirao, Kuniaki [4 ]
Kurose, Koichi [5 ]
Saeki, Mayumi [6 ]
Ozawa, Shogo [7 ]
Kaniwa, Nahoko [5 ]
Hirohashi, Setsuo [8 ]
Saijo, Nagahiro [9 ]
Sawada, Jun-ichi [2 ]
Yoshida, Teruhiko [3 ]
机构：
[1] Natl Inst Hlth Sci, Div Biosignaling, Setagaya Ku, Tokyo 1588501, Japan
[2] Natl Inst Hlth Sci, Dept Biochem & Immunochem, Setagaya Ku, Tokyo 1588501, Japan
[3] Natl Inst Canc Res, Div Genet, Chuo Ku, Tokyo 1040045, Japan
[4] Natl Canc Ctr, Div Internal Med, Chuo Ku, Tokyo 1040045, Japan
[5] Natl Inst Hlth Sci, Div Med Safety Sci, Setagaya Ku, Tokyo 1588501, Japan
[6] Natl Inst Hlth Sci, Project Team Pharmacogenet, Setagaya Ku, Tokyo 1588501, Japan
[7] Natl Inst Hlth Sci, Div Pharmacol, Setagaya Ku, Tokyo 1588501, Japan
[8] Natl Inst Canc Res, Div Pathol, Chuo Ku, Tokyo 1040045, Japan
[9] Natl Canc Ctr Hosp E, Chiba 2778577, Japan
来源：
CANCER LETTERS | 2008年 / 261卷 / 02期
关键词：
UGT1A1; pharmacogenetics; irinotecan; SN-38;
D O I：
10.1016/j.canlet.2007.11.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Recent pharmacogenetic studies on irinotecan have revealed the impact of UDP glucuronosyltransferase (UGT) 1A1*28 on severe irinotecan toxicities. Although the clinical role of UGT1A1*6, which is specifically detected in East Asian patients, in irinotecan toxicities is suggested, clear evidence remains limited. To examine the impact of *6, the association of UGT1A1 genotypes with severe irinotecan toxicities was retrospectively investigated in Japanese cancer patients. A significant *6-dependent increase in the incidence of grade 3 or 4 neutropenia was observed in 49 patients on irinotecan mono-therapy (p = 0.012). This study further clarifies the clinical importance of *6 in irinotecan therapy in East Asians. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：165 / 171
页数：7
相关论文
共 50 条
  • [41] Comparison of the inhibition potentials of icotinib and erlotinib against human UDP-glucuronosyltransferase 1A1
    Xuewei Cheng
    Xia Lv
    Hengyan Qu
    Dandan Li
    Mengmeng Hu
    Wenzhi Guo
    Guangbo Ge
    Ruihua Dong
    Acta Pharmaceutica Sinica B, 2017, 7 (06) : 657 - 664
  • [42] Comparison of the inhibition potentials of icotinib and erlotinib against human UDP-glucuronosyltransferase 1A1
    Cheng, Xuewei
    Lv, Xia
    Qu, Hengyan
    Li, Dandan
    Hu, Mengmeng
    Guo, Wenzhi
    Ge, Guangbo
    Dong, Ruihua
    ACTA PHARMACEUTICA SINICA B, 2017, 7 (06) : 657 - 664
  • [43] Effect of UDP-glucuronosyltransferase 1A1 activity on risk for developing Gilbert's syndrome
    Huang, May-Jen
    Chen, Yi-Chun
    Huang, Yang-Yang
    Yang, Sien-Sing
    Chen, Pei-Lain
    Huang, Ching-Shan
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2019, 35 (07): : 432 - 439
  • [44] TokyoGreen derivatives as specific and practical fluorescent probes for UDP-glucuronosyltransferase (UGT) 1A1
    Terai, Takuya
    Tomiyasu, Rie
    Ota, Tomoe
    Ueno, Tasuku
    Komatsu, Toru
    Hanaoka, Kenjiro
    Urano, Yasuteru
    Nagano, Tetsuo
    CHEMICAL COMMUNICATIONS, 2013, 49 (30) : 3101 - 3103
  • [45] The importance of cysteine 126 in the human liver UDP-glucuronosyltransferase UGT1A6
    Senay, C
    Jedlitschky, G
    Terrier, N
    Burchell, B
    Magdalou, J
    Fournel-Gigleux, S
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2002, 1597 (01): : 90 - 96
  • [46] Accelerated degradation of abnormal UDP-glucuronosyltransferase form 1A1 (UGT1A1) by proteasome
    Emi, Y
    Ohnishi, A
    Ikushiro, S
    Iyanagi, T
    DRUG METABOLISM REVIEWS, 2003, 35 : 58 - 58
  • [47] Differential Regulation of Hepatic UDP-glucuronosyltransferase (UGT) 1A1 by Toll-like Receptors during Irinotecan-induced Steatosis
    Tao, Gabriel
    Chityala, Pavan
    Ghose, Romi
    FASEB JOURNAL, 2020, 34
  • [48] Genetic polymorphisms in the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene and prostate cancer risk in Caucasian men
    Karatzas, Anastasios
    Giannatou, Eirini
    Tzortzis, Vassilios
    Gravas, Stavros
    Aravantinos, Evangellos
    Moutzouris, George
    Melekos, Michael
    Tsezou, Aspasia
    CANCER EPIDEMIOLOGY, 2010, 34 (03) : 345 - 349
  • [49] Regulation of UDP-Glucuronosyltransferase 1A1 Expression and Activity by MicroRNA 491-3p
    Dluzen, Douglas F.
    Sun, Dongxiao
    Salzberg, Anna C.
    Jones, Nate
    Bushey, Ryan T.
    Robertson, Gavin P.
    Lazarus, Philip
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2014, 348 (03): : 465 - 477
  • [50] Glucose induces intestinal human UDP-glucuronosyltransferase (UGT) 1A1 to prevent neonatal hyperbilirubinemia
    Aoshima, Naoya
    Fujie, Yoshiko
    Itoh, Tomoo
    Tukey, Robert H.
    Fujiwara, Ryoichi
    SCIENTIFIC REPORTS, 2014, 4
12345